MICRONASE Side Effects

6878306-6 | Loss Of Consciousness
on Jul 20, 2010 Female patient from UNITED STATES , weighting 215.0 lb, was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness. Micronase dosage: Unk.

6826612-3 | Blood Glucose Increased, Dizziness
Patient was taking Micronase (View Usage). Patient had the following side effects: blood glucose increased, dizziness (What is dizziness?) on Jul 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 244.0 lb, was diagnosed with diabetes mellitus, hypersensitivity and. Micronase dosage: 5 Mg, 1x/day. During the same period patient was treated with GLIMEPIRIDE (Unk) (View Glimepiride Review and Glimepiride Label ), ACTOS (Unk) (View Actos Review and Actos Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), CADUET (Unk) (View Caduet Review and Caduet Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), ALLEGRA (Unk) (View Allegra Review and Allegra Label ).

6813404-4 | Blood Glucose Increased, Dizziness
Adverse event was reported on Jun 24, 2010 by a Female patient taking Micronase (View Usage) (Dosage: 5 Mg, 1x/day) was diagnosed with diabetes mellitus, hypersensitivity and. Location: UNITED STATES , weighting 244.0 lb, After Micronase was administered, patient had the following side effects: blood glucose increased, dizziness (What is dizziness?). During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ACTOS (Unk) (View Actos Review and Actos Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), CADUET (Unk) (View Caduet Review and Caduet Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), ALLEGRA (Unk) (View Allegra Review and Allegra Label ).

6568920-X | Blood Sodium Decreased, Neuralgia
on Jan 29, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with diabetes mellitus, neuralgia and was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, neuralgia. Micronase dosage: 5 Mg, 1x/day. During the same period patient was treated with TEGRETOL (Unk) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.


6212167-3 | Blood Glucose Decreased, Blood Glucose Increased, Cholecystectomy, Transient Ischaemic Attack
on May 18, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with diabetes mellitus, blood glucose abnormal and was treated with Micronase (View Usage). Patient had the following side effects: blood glucose decreased, blood glucose increased, cholecystectomy, transient ischaemic attack. Micronase dosage: 10 Mg, 2x/day. During the same period patient was treated with GLIBENCLAMIDE (10 Mg, 2x/day) (View Glibenclamide Review and Glibenclamide Label ), ACTOS (30 Unk, Unk) (View Actos Review and Actos Label ), ZETIA (Unk) (View Zetia Review and Zetia Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6181092-9 | Asthenia, Blood Glucose Decreased, Blood Glucose Increased, Body Height Decreased, Cardiac Disorder, Diarrhoea, Dizziness, Flatulence, Glycosylated Haemoglobin Increased
Patient was taking Micronase (View Usage). After Micronase was administered, patient had the following side effects: asthenia, blood glucose decreased, blood glucose increased, body height decreased, cardiac disorder, diarrhoea, dizziness (What is dizziness?), flatulence, glycosylated haemoglobin increased on May 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 153.9 lb, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and. Micronase dosage: 10 Mg, 2x/day. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), GLIPIZIDE (10 Mg, 2x/day) (View Glipizide Review and Glipizide Label ), AVANDIA (View Avandia Review and Avandia Label ), GLUCOPHAGE (750 Mg, 2x/day) (View Glucophage Review and Glucophage Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ). Patient was hospitalized.

6152835-5 | Blood Glucose Decreased, Blood Glucose Increased, Cholecystectomy, Transient Ischaemic Attack
Adverse event was reported on Apr 13, 2009 by a Female patient taking Micronase (View Usage) (Dosage: 10 Mg, 2x/day) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, cholecystectomy, transient ischaemic attack. During the same period patient was treated with GLIBENCLAMIDE (10 Mg, 2x/day) (View Glibenclamide Review and Glibenclamide Label ), ACTOS (Unk) (View Actos Review and Actos Label ), ZETIA (Unk) (View Zetia Review and Zetia Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6111838-7 | Asthenia, Blood Glucose Decreased, Blood Glucose Increased, Body Height Decreased, Cardiac Disorder, Diarrhoea, Dizziness, Flatulence, Glycosylated Haemoglobin Increased
on Feb 27, 2009 Female patient from UNITED STATES , weighting 153.9 lb, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and was treated with Micronase (View Usage). Patient had the following side effects: asthenia, blood glucose decreased, blood glucose increased, body height decreased, cardiac disorder, diarrhoea, dizziness (What is dizziness?), flatulence, glycosylated haemoglobin increased. Micronase dosage: 10 Mg, 2x/day. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), GLIPIZIDE (10 Mg, 2x/day) (View Glipizide Review and Glipizide Label ), AVANDIA (View Avandia Review and Avandia Label ), GLUCOPHAGE (750 Mg, 2x/day) (View Glucophage Review and Glucophage Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ). Patient was hospitalized.

6108424-1 | Pancreatitis, Weight Decreased
on Feb 25, 2009 Female patient from UNITED STATES , weighting 122.0 lb, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). After Micronase was administered, patient had the following side effects: pancreatitis, weight decreased. Micronase dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ).

6106075-6 | Abdominal Operation
Patient was taking Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal operation on Mar 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and. Micronase dosage: . During the same period patient was treated with PREVACID (Unk) (View Prevacid Review and Prevacid Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), CYMBALTA (Unk) (View Cymbalta Review and Cymbalta Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), ZESTRIL (Unk) (View Zestril Review and Zestril Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ), DOXEPIN HYDROCHLORIDE (Unk) (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ). Patient was hospitalized.

6103145-3 | Blood Glucose Decreased, Blood Glucose Increased, Cholecystectomy, Transient Ischaemic Attack
Adverse event was reported on Feb 20, 2009 by a Female patient taking Micronase (View Usage) (Dosage: 10 Mg, 2x/day) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 140.0 lb, Patient had the following side effects: blood glucose decreased, blood glucose increased, cholecystectomy, transient ischaemic attack. During the same period patient was treated with GLIBENCLAMIDE (10 Mg, 2x/day) (View Glibenclamide Review and Glibenclamide Label ), ACTOS (Unk) (View Actos Review and Actos Label ), ZETIA (Unk) (View Zetia Review and Zetia Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6063123-X | Abdominal Operation
on Jan 28, 2009 Female patient from UNITED STATES , weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Micronase (View Usage). After Micronase was administered, patient had the following side effects: abdominal operation. Micronase dosage: . During the same period patient was treated with PREVACID (Unk) (View Prevacid Review and Prevacid Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), CYMBALTA (Unk) (View Cymbalta Review and Cymbalta Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), ZESTRIL (Unk) (View Zestril Review and Zestril Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ), DOXEPIN HYDROCHLORIDE (Unk) (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ). Patient was hospitalized.

6025467-7 | Blood Glucose Decreased, Blood Glucose Increased, Cardiac Disorder, Diarrhoea, Flatulence, Glycosylated Haemoglobin Increased, Pneumonia
on Dec 22, 2008 Female patient from UNITED STATES , weighting 153.9 lb, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, cardiac disorder, diarrhoea, flatulence, glycosylated haemoglobin increased, pneumonia (What is pneumonia?). Micronase dosage: 10 Mg, 2x/day. During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), AVANDIA (View Avandia Review and Avandia Label ), GLUCOPHAGE (750 Mg, 2x/day) (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

5036812-3 | Blood Glucose Fluctuation, Hypoglycaemia
Patient was taking Micronase (View Usage). Patient had the following side effects: blood glucose fluctuation, hypoglycaemia on May 10, 2005 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 185.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and. Micronase dosage: 2.5 Mg (2.5 Mg, 1 In 1 D), Oral. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ).

5019257-1 | Hypoglycaemia
Adverse event was reported on May 19, 2006 by a Male patient taking Micronase (View Usage) (Dosage: 30 Mg (10 Mg, 3 In 1 D)) was diagnosed with diabetes mellitus non-insulin-dependent, ill-defined disorder, bronchitis (What is bronchitis?) and. Location: UNITED STATES , 56 years of age, weighting 187.4 lb, After Micronase was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), KETEK (800 Mg (800 Mg, 1 In 1 D), Oral) (View Ketek Review and Ketek Label ), METFORMIN (View Metformin Review and Metformin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

5013794-1 | Blood Glucose Decreased, Cardiac Failure, Pneumonia Aspiration, Renal Failure
on May 26, 2006 Female patient from UNITED STATES , 82 years of age, was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, cardiac failure, pneumonia aspiration, renal failure. Micronase dosage: Tablet.

4964021-2 | Cardiac Failure Congestive, Rash
on Mar 23, 2006 Male patient from UNITED STATES , 73 years of age, was diagnosed with ill-defined disorder and was treated with Micronase (View Usage). Patient had the following side effects: cardiac failure congestive, rash (What is rash?). Micronase dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PLAVIX (View Plavix Review and Plavix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PRED FORTE (View Pred Forte Review and Pred Forte Label ). Patient was hospitalized.

4957088-9 | Hypoglycaemia
Patient was taking Micronase (View Usage). After Micronase was administered, patient had the following side effects: hypoglycaemia on Mar 15, 2006 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 187.4 lb, was diagnosed with diabetes mellitus non-insulin-dependent, ill-defined disorder, bronchitis (What is bronchitis?) and. Micronase dosage: 30 Mg (10 Mg, 3 In 1 D). During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), KETEK (800 Mg (800 Mg, 1 In 1 D), Oral) (View Ketek Review and Ketek Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

4867146-5 | Acute Coronary Syndrome, Acute Myocardial Infarction, Aortic Valve Incompetence, Aortic Valve Sclerosis, Cardiac Failure Congestive, Cardiomegaly, Carotid Artery Stenosis, Chest X-ray Abnormal, Impaired Healing
Adverse event was reported on Dec 12, 2005 by a Male patient taking Micronase (View Usage) (Dosage: 15 Mg (15 Mg, 1 In 1 D), Oral) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, cardiomegaly, carotid artery stenosis, chest x-ray abnormal, impaired healing. During the same period patient was treated with MURAGLITAZAR (MURAGLITAZAR) (15 Mg (1 In 1 D), Oral) (View Muraglitazar (muraglitazar) Review and Muraglitazar (muraglitazar) Label ), ZOCOR (View Zocor Review and Zocor Label ), ACCUPRIL (View Accupril Review and Accupril Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4811010-4 | Acute Coronary Syndrome, Acute Myocardial Infarction, Aortic Valve Incompetence, Aortic Valve Sclerosis, Cardiac Failure Congestive, Cardiomegaly, Carotid Artery Stenosis, Contrast Media Reaction, Diastolic Dysfunction
on Oct 12, 2005 Male patient from UNITED STATES , 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, cardiomegaly, carotid artery stenosis, contrast media reaction, diastolic dysfunction. Micronase dosage: 15 Mg (15 Mg, 1 In 1 D), Oral. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), ACCUPRIL (View Accupril Review and Accupril Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4735197-7 | Blood Glucose Decreased, Feeling Abnormal, Muscle Spasms, Nausea, Stomach Discomfort
on Jul 21, 2005 Female patient from UNITED STATES , 61 years of age, was diagnosed with diabetes mellitus, fibromyalgia and was treated with Micronase (View Usage). After Micronase was administered, patient had the following side effects: blood glucose decreased, feeling abnormal, muscle spasms, nausea (What is nausea?), stomach discomfort. Micronase dosage: Unk (2 In 1 D), Oral. During the same period patient was treated with VOLTAREN XR (Unk (2 In 1 D); Oral) (View Voltaren-xr Review and Voltaren-xr Label ), VOLTAREN XR (Unk (2 In 1 D); Oral) (View Voltaren-xr Review and Voltaren-xr Label ), AVANDIA (View Avandia Review and Avandia Label ), TENORMIN (View Tenormin Review and Tenormin Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

4634657-7 | Acute Coronary Syndrome, Angiopathy, Aortic Valve Incompetence, Aortic Valve Sclerosis, Blood Pressure Increased, Cardiac Failure Congestive, Cardiomegaly, Carotid Artery Stenosis, Chest Discomfort
Patient was taking Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, angiopathy, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis, chest discomfort on Mar 31, 2005 from Additional patient health information: Male patient , 67 years of age, was diagnosed with diabetes mellitus and. Micronase dosage: 15 Mg (15 Mg, 1 In 1 D), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ), AMLODIPINE BESILATE (AMLODIPINE BESILATE0 (View Amlodipine Besilate (amlodipine Besilate0 Review and Amlodipine Besilate (amlodipine Besilate0 Label ), CETIRIZINE HYDROCHLORIDE (CETERIZINE HYDROCHLORIDE) (View Cetirizine Hydrochloride (ceterizine Hydrochloride) Review and Cetirizine Hydrochloride (ceterizine Hydrochloride) Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ). Patient was hospitalized.

4602689-0 | Acute Coronary Syndrome, Acute Myocardial Infarction, Angiopathy, Aortic Valve Incompetence, Aortic Valve Sclerosis, Blood Pressure Increased, Cardiac Failure Congestive, Cardiomegaly, Carotid Artery Stenosis
Adverse event was reported on Feb 22, 2005 by a Male patient taking Micronase (View Usage) (Dosage: 15 Mg (15 Mg, 1 In 1 D), Oral) was diagnosed with diabetes mellitus and. Location: , 67 years of age, Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, angiopathy, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ).

4592547-2 | Acute Myocardial Infarction, Aortic Aneurysm, Aortic Valve Incompetence, Aortic Valve Sclerosis, Cardiac Failure Congestive, Carotid Artery Stenosis, Ejection Fraction Decreased, Impaired Healing, Mitral Valve Calcification
on Feb 16, 2005 Male patient from , 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). After Micronase was administered, patient had the following side effects: acute myocardial infarction, aortic aneurysm (What is aortic aneurysm?), aortic valve incompetence, aortic valve sclerosis, cardiac failure congestive, carotid artery stenosis, ejection fraction decreased, impaired healing, mitral valve calcification. Micronase dosage: 15 Mg (15 Mg, 1 In 1 D), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CANDESARTAN CILEXETIL (CANDESARTANN CILEXETIL) (View Candesartan Cilexetil (candesartann Cilexetil) Review and Candesartan Cilexetil (candesartann Cilexetil) Label ), FEXOFENADINE HYDROCHLORIDE 9FEXOFENADINE HYDROCHLORIDE) (View Fexofenadine Hydrochloride 9fexofenadine Hydrochloride) Review and Fexofenadine Hydrochloride 9fexofenadine Hydrochloride) Label ). Patient was hospitalized.

4587462-4 | Blood Glucose Fluctuation, Facial Spasm, Muscle Spasms, Myoclonus, Tension, Tremor
on Feb 02, 2005 Male patient from , 91 years of age, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, facial spasm, muscle spasms, myoclonus, tension, tremor. Micronase dosage: 7.5 Mg (3.5 Mg,daily), Oral. During the same period patient was treated with DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), FOLACIN (CALCIUM PHOSPHATE, FOLIC ACID) (View Folacin (calcium Phosphate, Folic Acid) Review and Folacin (calcium Phosphate, Folic Acid) Label ), CYANOCOBALAMIN TANNIN COMPLEX (CYANOCOBALAMIN TANNIN COMPLEX) (View Cyanocobalamin-tannin Complex (cyanocobalamin-tannin Complex) Review and Cyanocobalamin-tannin Complex (cyanocobalamin-tannin Complex) Label ). Patient was hospitalized.

4583639-2 | Acute Myocardial Infarction, Aortic Valve Incompetence, Aortic Valve Sclerosis, Blood Pressure Increased, Cardiac Failure Congestive, Cardiomegaly, Carotid Artery Stenosis, Contrast Media Reaction, Coronary Artery Disease
Patient was taking Micronase (View Usage). Patient had the following side effects: acute myocardial infarction, aortic valve incompetence, aortic valve sclerosis, blood pressure increased, cardiac failure congestive, cardiomegaly, carotid artery stenosis, contrast media reaction, coronary artery disease (What is coronary artery disease?) on Jan 31, 2005 from Additional patient health information: Male patient , 67 years of age, was diagnosed with diabetes mellitus and. Micronase dosage: 15 Mg (15 Mg, Daily), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HYDROCHLORIDE (QUINARPIL HYDROCHLORIDE) (View Quinapril Hydrochloride (quinarpil Hydrochloride) Review and Quinapril Hydrochloride (quinarpil Hydrochloride) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), FEXOFENADINE HYDROCHLORIDE (FEXOFEXADINE HYDROHCLORIDE) (View Fexofenadine Hydrochloride (fexofexadine Hydrohcloride) Review and Fexofenadine Hydrochloride (fexofexadine Hydrohcloride) Label ). Patient was hospitalized.

4565198-3 | Rash
Adverse event was reported on Jan 27, 2005 by a Female patient taking Micronase (View Usage) (Dosage: 5 Mg Po Qd) was diagnosed with diabetes mellitus and. Location: , weighting 156.0 lb, After Micronase was administered, patient had the following side effects: rash (What is rash?).

4562211-4 | Aortic Atherosclerosis, Arterial Occlusive Disease, Cardiomegaly, Cerebral Atrophy, Circulatory Collapse, Coronary Artery Atherosclerosis, Dyspnoea, Hepatomegaly, Hydrocephalus
on Jan 11, 2005 Male patient from , 63 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Micronase (View Usage). Patient experienced the following unwanted or unexpected effects: aortic atherosclerosis, arterial occlusive disease, cardiomegaly, cerebral atrophy, circulatory collapse, coronary artery atherosclerosis, dyspnoea, hepatomegaly, hydrocephalus (What is hydrocephalus?). Micronase dosage: Oral. During the same period patient was treated with PRINZIDE (View Prinzide Review and Prinzide Label ), ATORVASTATIN (ATORVASTATIN) (View Atorvastatin (atorvastatin) Review and Atorvastatin (atorvastatin) Label ).

4558714-9 | Acute Coronary Syndrome, Acute Myocardial Infarction, Cardiac Failure Congestive, Carotid Artery Stenosis, Coronary Artery Disease, Pulmonary Oedema, Renal Failure Acute
on Jan 11, 2005 Male patient from , 67 years of age, was diagnosed with diabetes mellitus and was treated with Micronase (View Usage). Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, cardiac failure congestive, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), pulmonary oedema, renal failure acute. Micronase dosage: 15 Mg (15 Mg, Daily), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ). Patient was hospitalized.